Results 41 to 50 of about 18,768 (157)
Regulation of TGF-β1, 2, and 3 and IL-10 at systemic level in chronic liver disease
Annals of HepatologyIntroduction and Objectives: Chronic liver disease (CLD) is considered an important health problem worldwide. The production of IL-10 regulated the hepatic inflammation.
Marisela Hernandez-Santillan +12 more
doaj +1 more source
Hernia diafragmática del hígado [PDF]
, 2022 En el hígado de un ternero, sacrificado en el frigorífico «La Blanca», fue encontrado por el doctor G. Bazterrica un tumor localizado en la cara anterior del órgano. Su forma, su aspecto, su modo de adherir al hígado, en una palabra, todos sus caracteres
Blomberg, Eduardo
core
Segmentación semiautomática del volumen del hígado en imágenes de tomografía computarizada [PDF]
, 2010 El volumen del hígado es un parámetro determinante en cirugía para la extracción de tumores, trasplantes, y en tratamientos de regeneración. Generalmente, la estimación de este volumen se calcula a partir de segmentaciones manuales realizadas por ...
Romero Castro, Edgar Eduardo +2 more
core +2 more sources
Annals of HepatologyIntroduction and Objectives: The high disease burden and limited survival of cirrhotic patients with hepatocarcinoma have led to the emphasis on the combination of atezolizumab and bevacizumab as first-line therapy.To describe the clinical ...
Jairo Cabanillas Espinoza +2 more
doaj +1 more source
COMPARISON OF CXCL-8 and IFN-γ PRODUCTION IN ACUTE AND CHRONIC STAGES OF LIVER DISEASE
Annals of Hepatology, 2022 Introduction and objective: Hepatitis C virus and alcoholism are the main causes of Chronic Liver Disease. (1) The increase of CXCL-8 has been correlated with mortality in alcoholic hepatitis (AH), while in Chronic Hepatitis C (CHC) with the disease ...
I. Altamirano-Mendoza +9 more
doaj +1 more source
MAFLD/MASLD: Past, Present, and Future
Journal of Gastroenterology and Hepatology, Volume 41, Issue 9, Page 2882-2892, September 2026.ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD), also known as nonalcoholic fatty liver disease and metabolic dysfunction‐associated fatty liver disease, affects more than 30% of the global adult population and has become one of the leading causes of cirrhosis and hepatocellular carcinoma.
Vincent Wai‐Sun Wong
wiley +1 more source
Liver International, Volume 46, Issue 7, July 2026.ABSTRACT Background and Aim Steatotic liver disease (SLD) is becoming increasingly prevalent, leading to a higher frequency of primary biliary cholangitis (PBC) cases coexisting with SLD. However, data on its impact in patients with PBC remain scarce.
María Del Barrio +38 more
wiley +1 more source
Manejo quirúrgico del quiste hidatídico multivisceral
Anales de la Facultad de MedicinaEl quiste hidatídico multivisceral constituye la presencia de quistes hidatidicos en más de un órgano de la cavidad abdominal. Generalmente, requieren manejo quirurgico complejo y tratamiento antiparasitario complementario.
Lucia Fernanda Galarreta-Galvez +2 more
doaj +1 more source
The burden of hepatic encephalopathy in Latin America
Annals of Hepatology, 2011 Hepatic encephalopathy (HE) is a neuropsychiatric syndrome characterized by changes in cognitive function, behavior, and personality, as well as by transient neurological symptoms and electroencephalographic changes, which occur in the context of acute ...
Milagros Dávalos Moscol +1 more
doaj +1 more source
Alimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 955-966, April 2026.In the phase I/IIa GOING trial, an add‐on strategy with regorafenib followed by nivolumab showed a manageable safety profile and meaningful clinical activity in second‐line hepatocellular carcinoma, with a median overall survival of 25 months and 45% three‐year survival in sorafenib‐experienced patients.
Marco Sanduzzi‐Zamparelli +24 more
wiley +1 more source